u.s.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment.
. (open access) shows that athletes of the mind � chess grandmasters � show the same longevity advantage as athletes of the body.
.
. and informal settlements. "this is far from the best start in life".
.